[Back to Overwiew]  [IACM Homepage]


IACM-Bulletin of 25 March 2020

IACM: Statement of the Board on current corona virus pandemic and the use of cannabinoids

Several laboratory studies suggest that cannabinoids may have antiviral and antibacterial effects. We have reported on this repeatedly in the IACM-Bulletin.

However, there is no evidence that individual cannabinoids -- such as CBD, CBG or THC -- or cannabis preparations protect against infection with the SARS-CoV2 virus or could be used to treat Covid-19, the disease produced by this virus.

Also, there is no evidence that the use of cannabinoids could increase the risk of viral infection.

Please do not pass on false information that is circulating on the Internet. Help contain the spread of the virus by following government and health authority guidelines.

Let us be in solidarity during this time, especially with those who are particularly at risk from such an infection.

Take care of yourself and others!

On behalf of the IACM Board of Directors

Dr. Kirsten Müller-Vahl (1st Chairwomen)
Dr. Franjo Grotenhermen (Executive Director)

A glimpse @ the past

One year ago

Two years ago

[Back to Overwiew]  [IACM Homepage]


up

IACM Conference 2020

The IACM will hold its 11th Conference on Cannabinoids in Medicine in collaboration with the Asociación Mexicana de Medicina Cannabinodie from 5 to 7 November 2020 in Mexico City. It will be a virtual congress

IACM Conference 2021

The 12th IACM Conference on Cannabinoids in Medicine will be held in Basel, Switzerland, from 14 to 16 October 2021.

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.